M4MM
Argent BioPharma Secures AU$11M Facility to Finalize AusCann Assets Purchase
SYDNEY – Argent BioPharma Ltd., a developer of cannabinoid-based treatments for neurological disorders, has arranged an AU$11 million convertible debt facility to close its pending acquisition of key assets from the defunct AusCann Group Holdings ...
West Virginia Medical Cannabis Costs Drive Patients Across State Lines for Lower-Priced Options
CHARLESTON – Elevated prices in West Virginia's medical Cannabis system continue to steer registered patients toward recreational outlets in Ohio, Maryland, and Michigan, where products sell at fractions of the cost despite legal barriers to ...
Florida Takes Action to Advance Adult-Use Cannabis Ballot Measure, Lawsuit Ends Delay
TALLAHASSEE – Florida election officials cleared a procedural roadblock for a proposed constitutional amendment to legalize recreational Cannabis, submitting the measure to the state attorney general's office just weeks after advocates sued over perceived delays ...
Circle K Eyes National Expansion for Hemp THC Drinks in 2026
LOS ANGELES – Circle K, the convenience store chain with nearly 7,000 locations across the United States, disclosed plans this week to distribute hemp-derived THC beverages in up to 3,000 stores starting next year. The ...
Manitoba Cannabis Sales Accelerate, Leaving Liquor in the Rearview
WINNIPEG – Cannabis revenues in Manitoba posted double-digit gains, handily surpassing liquor sales and underscoring the steady climb of the province's legal Cannabis trade. Manitoba Liquor & Lotteries, the corporation charged with distributing both products, ...
FLUENT Consolidates NY Retail Presence
NEW YORK – FLUENT Corp., a Cannabis operator with roots in Florida and Pennsylvania, has completed the rebranding of two key dispensaries in New York, bringing its retail operations in the state under a single ...
Australian Policy Group Cautions TGA on Medicinal Cannabis Restrictions, Fearing Shift to Illicit Sources
SYDNEY – A prominent drug policy organization in Australia has urged federal regulators to avoid curtailing access to prescription medicinal Cannabis, arguing that such steps could drive patients toward unregulated street supplies and erode the ...
Argent BioPharma Secures AU$11M Facility to Finalize AusCann Assets Purchase
SYDNEY – Argent BioPharma Ltd., a developer of cannabinoid-based treatments for neurological disorders, has arranged an AU$11 million convertible debt facility to close its pending acquisition of key assets from the defunct AusCann Group Holdings ...
West Virginia Medical Cannabis Costs Drive Patients Across State Lines for Lower-Priced Options
CHARLESTON – Elevated prices in West Virginia's medical Cannabis system continue to steer registered patients toward recreational outlets in Ohio, Maryland, and Michigan, where products sell at fractions of the cost despite legal barriers to ...
Florida Takes Action to Advance Adult-Use Cannabis Ballot Measure, Lawsuit Ends Delay
TALLAHASSEE – Florida election officials cleared a procedural roadblock for a proposed constitutional amendment to legalize recreational Cannabis, submitting the measure to the state attorney general's office just weeks after advocates sued over perceived delays ...
Canopy Growth Initiates $200 Million At-The-Market Equity Program
LOS ANGELES- Canopy Growth Corporation has established a new at-the-market (ATM) equity program, enabling the company to issue and sell up to $200 million in common shares across U.S. and Canadian markets. The company intends ...
GTI Q4 2024: Strong Leadership, But Can It Sustain Momentum?
NEW YORK–Green Thumb Industries (GTI) has once again demonstrated why it remains a leader in the U.S. cannabis industry. With a steady growth trajectory and disciplined financial management, the company continues to post strong results ...
Analysis: Movers and Shakers: Cannabis Quarterly Earnings
NEW YORK - Cannabis companies are reporting earnings from Q4 2024 and full year results. Here are just some of the results from the companies we are covering at HCN, in both cannabis and psychedelics: ...
Verano Holdings Reports 2024 Financial Results and Outlines 2025
LOS ANGELES- Verano Holdings Corp., a multi-state cannabis operator, has released its financial results for the fourth quarter and full year ending December 31, 2024, highlighting a decrease in revenue and an increase in net ...
Trulieve Reports Strong Fourth Quarter Performance
LOS ANGELES- Trulieve Cannabis Corp., a multi-state cannabis operator, has announced its financial results for the fourth quarter and full year ending December 31, 2024, showcasing notable growth and operational efficiency. Financial Highlights Revenue: The ...
Solvonis Therapeutics to Acquire Awakn Life Sciences in Strategic Biotech Merger
LOS ANGELES- Solvonis Therapeutics PLC, a UK-based biotechnology firm specializing in treatments for mental health and substance use disorders, has entered into an agreement to acquire Awakn Life Sciences Corp., a Toronto-based company developing therapeutics ...
Compass Pathways Projects FY2025 Net Cash Use of $120M-$145M
LOS ANGELES- Compass Pathways plc a mental health care company specializing in psilocybin therapy, has announced an expected net cash utilization of $120 million to $145 million for the fiscal year 2025. As of February ...
Cronos Group Reports $8.7 Million in Operating Expense Savings for FY2024
LOS ANGELES- Cronos Group Inc. has announced operating expense savings of $8.7 million for the fiscal year 2024, aligning with its previously stated target range of $5 million to $10 million. These savings were primarily ...
Minnesota Considers Allowing Liquor Wholesalers to Distribute Low-Potency Hemp Edibles
LOS ANGELES -A bipartisan bill introduced in the Minnesota House of Representatives seeks to permit licensed liquor wholesalers to distribute low-potency hemp edibles. Sponsored by Representatives Zack Stephenson (D) and Nolan West (R), House File ...
New Study Suggests Medical Cannabis Highly Cost-Effective Treatment for PTSD
LOS ANGELES-A recent study highlights the affordability and effectiveness of medical cannabis as a treatment for individuals with moderate post-traumatic stress disorder (PTSD). Conducted by researchers at Leafwell, the study suggests that medical cannabis could ...
Emerging Policies Reshape the Psychedelics Industry
LOS ANGELES- The psychedelics sector is undergoing significant transformations due to evolving regulatory policies and scientific advancements that could redefine their therapeutic applications. A notable development occurred in August 2024 when the U.S. Food and ...
Arizona’s Cannabis Sales Experience Downturn in 2024
LOS ANGELES- In 2024, Arizona's combined medical and adult-use cannabis market saw a decline, with total sales amounting to $1.1 billion, a decrease from the nearly $1.3 billion recorded in both 2022 and 2023. The ...
New Jersey Governor Proposes Increase to Cannabis Social Equity Tax
LOS ANGELES- Governor Phil Murphy has proposed raising New Jersey's social equity excise fee on cannabis from $2.50 to $15 per ounce. This proposal aims to generate additional revenue for social service and violence intervention ...
Industrial Hemp Regulation Undergoing Comprehensive Review
LOS ANGELES- The regulatory framework governing industrial hemp is currently under extensive review, aiming to address emerging challenges and align with evolving industry practices. This initiative seeks to refine existing policies to better support the ...
Cannara Biotech Extends BMO Credit Facility and Convertible Debenture to Strengthen Financial Position
LOS ANGELES- Cannara Biotech Inc. has announced the extension and amendment of its existing credit agreement with the Bank of Montreal (BMO) and a convertible debenture with Olymbec Investments Inc. These strategic financial adjustments aim ...
